Abstract: A method for spontaneous emulsification comprising mixing (i) an aqueous phase comprising a partitioning agent which contains a partitioning anion which determines the hydrophilicity of the partitioning agent, alone or in further combination with an electrolyte, with (ii) an oil phase comprising a phase-transfer agent, wherein the phase-transfer agent creates and promotes an interfacial flux of an anion and promotes the formation of droplets at a liquid-liquid interface of the aqueous phase and oil phase; and a method for spontaneous electro-emulsification comprising generating an ionic flux across the liquid-liquid interface by applying an electrical potential.

Abstract: According to one embodiment, an apparatus is disclosed for implementing a radio frequency quadrupole stark decelerator (RFQ-SD). The RFQ-SD includes two dielectric plates having substantially planar shapes. The first dielectric plate includes a first set of wires being attached onto a surface of the first dielectric plate and a second set of wires being attached onto the surface of the first dielectric plate. The second dielectric plate includes a third set of wires being attached onto a surface of the second dielectric plate and a fourth set of wires being attached onto the surface of the second dielectric plate. The first dielectric plate and the second dielectric plate are spaced apart such that every four wires, two wires from the first dielectric plate and two wires from the second dielectric plate, form a quadrupole electric field channel for guiding neutral polar molecules.

Abstract: The present invention provides sequence specific restriction enzymes for site-specific cleavage of RNA, as well as methods of their use.

Abstract: Provided herein are small molecule compounds, including non-anticoagulant heparan sulfate oligosaccharide molecules, having anti-inflammatory properties and capable of interacting with high mobility group box 1 (HMGB1) proteins in a manner sufficient to affect an interaction between the HMGB1 protein and a receptor for advanced glycation end products (RAGE). Also provided herein are methods of treating Paracetamol (APAP) overdose in subjects.

Abstract: How to correctly understand natural language query and catch the useful information from it is a long-standing research question in the chatbot field. However, in many cases only a small set of words are sufficient for closed-domain tasks. In this paper, we propose Minimal Dictionary Language (MDL): a simple language architecture which allows users to express their needs through certain basic syntax. For the pilot study, we selected Enron email open dataset[2] for our experimental use and apply MDL as the language for email retrieval task. We also built a front-end search interface by Python Flask and Vue.js for test and evaluation purposes.

Abstract: Interferon-?-inducible protein 10 (IP-10) peptides, IP-10 peptide variants and in silico designed C-X-C chemokine receptor 3 (CXCR3) peptide agonists are described. The small peptides can be used for inhibiting pathological tissue remodeling and treating fibrosis in a subject, such as a subject with fibrosis of the heart, lung, liver, kidney or skin. The peptide agonists can also be used to treat cardiovascular disease, including myocardial infarction and ischemia-reperfusion injury. Also described are in silico designed peptide antagonists that bind CXCR3 or ligands of CXCR3. These antagonist peptides block CXCR3 signaling by disrupting interaction of CXCR3 with its ligand. Antagonist peptides can be used, for example, to treat myocarditis and atherosclerosis. In additional embodiments agonists and antagonists of CXCR4 are disclosed.

Abstract: A miniature electrode apparatus is disclosed for trapping charged particles, the apparatus includes, along a longitudinal direction, a first end cap electrode, a central electrode having an aperture, and a second end cap electrode. The aperture is elongated in the lateral plane and extends through the central electrode along the longitudinal direction and the central electrode surrounds the aperture in a lateral plane perpendicular to the longitudinal direction to define a transverse cavity for trapping charged particles. Electric fields can be applied in a y-direction of the lateral plane across one or more planes perpendicular to the longitudinal axis to translocate and/or manipulate ion trajectories.

Abstract: Stable nucleic acid liquid formulations and methods of making and using the same are provided. According to some aspects, a method for preparing stable nucleic acid liquid formulations are provided that are resistant to nucleic acid degradation caused by enzyme-independent or enzymatic hydrolysis. In some instances, stable nucleic acid liquid compositions and methods or making the same incorporate the use of at least one of a polymer and/or a salt to form a macroscopic RNA-rich condensate. In other aspects, a method for preparing stable nucleic acid encapsulated lipid nanoparticle (LNP) liquid formulations is provided that are resistant to degradation caused by nucleic acid hydrolysis, LNP leakage, and LNP aggregation. In some instances, stable nucleic acid liquid compositions and methods or making the same incorporate the use of a pair of thermodynamically matching LNP synthesis buffer and LNP product formulation buffer with close-to-equal osmotic pressure and chemical potentials of solution components.

Abstract: The present disclosure provides humanized antibodies and antigen-binding fragments thereof that specifically bind to SFRP2 and compositions comprising such humanized antibodies or antigen-binding fragments thereof. In some aspects, the humanized antibodies or antigen-binding fragments can be used to treat diseases or conditions associated with increased SFRP2, such as cancer. In some aspects, the antibodies or antigen-binding fragments can be used to treat osteosarcoma.

Abstract: Methods and compositions are provided for determining a subtype of head and neck squamous cell carcinoma (HNSCC) of an individual by detecting the expression level of at least one classifier biomarker selected from a group of gene signatures for HNSCC. Also provided herein are methods and compositions for determining the response of an individual with a HNSCC subtype to a therapy such as immunotherapy.

Abstract: In one aspect, compounds and associated pharmaceutical compositions are described herein for the treatment of various fungal infections and/or other diseases. In some embodiments, a method for the inactivation of a microbial enzyme is provided comprising providing a compound having a selective inactivation activity, providing an enzyme target, and inactivating the enzyme target. In some example embodiments, the compound comprises a sulfonyl group.

Abstract: Provided are methods for identifying pancreatic cancer subtypes in a subject and treating the same. In some embodiments, the method comprise obtaining gene expression levels for each of the following genes in the biological sample: GPR87, KRT6A, BCAR3, PTGES, 1TGA3, C16orf74, S100A2, KRT5, REG4, ANXA10, GATA6, CLDN18, LGALS4, DDC, SLC40A1, CLRN3; performing pair-wise comparisons of gene expression levels for combinations of these genes, and calculating a Raw Score for the biological sample, wherein the Raw Score is indicative of the pancreatic cancer subtype in the subject. Also provided are methods for identifying differential treatment strategies for subjects diagnosed with PDAC, methods for treating PDAC patients based on the subtype of PD AC the patients have; and methods for classifying subjects diagnosed with PDAC as having a basal-like subtype or a classical subtype of PDAC.

Abstract: In one aspect, compounds and associated pharmaceutical compositions are described herein comprising isolated cannabicitran (CBT-C (3)). In some embodiments, CBT-C (3) enantiomers are isolated and/or prepared. In some further embodiments, the biological activity of enantiomers are determined. In some further embodiments, one or more enantiomers may be incorporated into a composition.

Abstract: Methods of synthesizing chondroitin sulfate oligosaccharides are provided. Enzymatic schematic approaches to synthesizing structurally defined homogenous chondroitin sulfate oligosaccharides at high yields are provided. Synthetic chondroitin sulfate oligosaccharides ranging from 3-mers to 15-mers are provided.

Abstract: Apparatuses and methods of the present disclosure integrate a non-intrusive current sensor in the form of a current mismatch sensor into a power module having paralleled semiconductor structures or components. The current mismatch can be detected by the current sensor by monitoring a magnetic flux density between the paralleled components or devices.

Abstract: Methods of operating a grid ancillary service with an uninterruptible power supply (GAUPS) device are provided. A method of operating a GAUPS device includes controlling a switch of the GAUPS device in response to a signal that is generated by the switch, to control efficiency of an inverter and quality of power supplied to a load via the inverter. The switch is coupled between the inverter and the load. Related systems and devices are also provided.

Abstract: The present invention provides fully IgG bi-specific antibodies comprising designed residues in the interface of the heavy chain-heavy chain (CH3/CH3) domains, processes for preparing said fully IgG bi-specific antibodies, and nucleic acids, vectors and host cells encoding the same.

Abstract: The invention generally relates to linear-bottlebrush-linear copolymer blocks and methods of making and using same. The disclosed copolymer blocks can be useful in, for example, the formation of polymer networks that replicate biological stress-strain behavior. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Abstract: Methods, systems, and computer readable media for utilizing visuomotor error augmentation for balance rehabilitation are provided. An exemplary method includes displaying a dynamic virtual environment defined by an optical flow, obtaining position data of an anatomical portion of a subject that is virtually traversing the dynamic virtual environment, and using the position data to determine a mediolateral displacement measurement of the subject. The method further includes utilizing the mediolateral displacement measurement to define feedback control loop data, establishing an augmented visual error that dynamically adjusts the dynamic virtual environment, wherein the augmented visual error is based on the feedback control loop data and a predefined visual gain factor, and adjusting the optical flow of the dynamic virtual environment by using the augmented visual error.

Abstract: The subject matter described herein relates to methods, systems, and computer readable media for dynamic cluster-based search and retrieval. An example method for dynamic cluster-based search and retrieval occurs at a server.